AMNEAL AND IMPAX TO COMBINE
Combination Creates Diversified Pharmaceutical Company with 5th Largest Generics Business in the United States Combined Company to Benefit from Expanded Generics Product Portfolio, Premier Diversified Generics Pipeline, Broad R&D Capabilities Across Dosage Forms, High-Quality and Low-Cost Global Manufacturing and Distribution Network, and Enhanced Financial Foundation Combined Company to Have Industry-Leading Growth Profile with Annual …